Tweets & News

Apostle Inc is pleased to announce that the company is going to present at the 5th Liquid Biopsy Summit, to take place in Seattle, WA on June 15-17, 2020. David Ge, CEO of Apostle, will discuss Apostle MiniEnrich, a novel method for enrichment of short DNA fragments for NIPT and oncology applications. read more

Apostle Inc is pleased to announce the appointment of Antonius ‘Toni’ Schuh, PhD - a successful serial entrepreneur and founder in the life sciences industries as CEOs of 5 companies with 3 IPOs - as a new member to its Board of Advisors. read more

Apostle Inc presents at the Precision Medicine World Conference 2020 held in Santa Clara, California. read more

Apostle Inc is pleased to announce the appointment of Mr. Eric D. Masingale as its Vice President of Business Operations. read more

Apostle Inc is pleased to announce the completion of its series A financing. read more

Apostle Inc is pleased to receive the Certificates of Conformance to certify its Quality Management System. read more

Apostle Inc is pleased to announce an exclusive partnership with Beckman Coulter, a world leader in Life Sciences, for Apostle MiniMax(TM) High Efficiency Cell-Free DNA Isolation Kit. read more

Apostle's manufacturing facility located in Shenzhen, China obtains ISO9001:2015 certification. read more

Apostle is elected into the StartX Accelerator Program (Summer 2018 session), one of the most pretigeous accelerator programs in the Silicon Valley. read more

Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. read more

Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. read more

Apostle won the Second Place in the Final of North America Region, CACSC，(Create@AlibabaCloud Startup Contest). Over 300 startups from North America have competed in CACSC, and 13 entered the final. read more

Apostle Inc is pleased to announce the appointment of Dean W. Felsher, MD, PhD as a new member to its Scientific Advisory Board. Dr. Felsher is Professor of Medicine in Departments of Oncology and Pathology at Stanford University School of Medicine. He is Director of Stanford Translational Research and Applied Medicine (TRAM) as well as Director of Oncology Research, Division of Oncology at Stanford. read more

Apostle Inc is selected into the Amazon Web Service (AWS) Activate Program. The AWS Activate Portfolio Package received by Apostle includes a one-year AWS Gold Premium Support and a two-year AWS usage credit. read more

Forbes China named Apostle Inc’s co-Founder and VP of Chemistry, Bo Zhang, PhD, as one of the most brilliant young entrepreneurs in its annual “30 Under 30 China” list in the category of healthcare and science. read more

Apostle Inc is pleased to announce the appointment of William Dai, MBA as a new member to its Board of Directors, and Charles Cantor, PhD and Hongyu Zhao, PhD as new members to its Advisory Board. read more

Apostle Inc today led a round-table discussion at the 7th Asia Pharma R&D Leaders 2017, held in Shanghai, China.

Apostle CEO David Ge is invited to be on the Advisory Board of the 13th Annual Biomarkers Congress, organized by the Oxford Global and to be held in February 2018 in Manchester, UK.

Apostle Inc, a biotechnology company focusing on liquid biopsy, is founded in the Silicon Valley. read more